1-2 of 2
Liza C. Villaruz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
Journal: Cancer Research Communications
Cancer Research Communications (2024) 4 (3): 785.
https://doi.org/10.1158/2767-9764.CRC-24-0133
Published: 13 March 2024
View article titled, Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Open the PDF for Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study in another window
Journal Articles

Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (12): 2572–2584.
https://doi.org/10.1158/2767-9764.CRC-22-0461
Published: 19 December 2023
View article titled, Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Open the PDF for Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study in another window
Includes: Supplementary data